Inventor
EICHHORN ERIC
CH17 patents
⚠️ This page may combine multiple inventors who share the name “EICHHORN ERIC”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GIVAUDAN SA
15 patentsUS10472655B2Nov 12, 2019
Enzymes and applications thereof
GIVAUDAN SA5 citations81
US10844412B2Nov 24, 2020
Solid form of (−)-Ambrox formed by a bioconversion of homofarnesol in the presence of a biocatalyst
GIVAUDAN SA4 citations79
US11965195B2Apr 23, 2024
Enzyme mediated process
GIVAUDAN SA2 citations72
US11466299B2Oct 11, 2022
Enzymes and applications thereof
GIVAUDAN SA2 citations70
US11021722B2Jun 1, 2021
Enzymes and applications thereof
GIVAUDAN SA1 citations70
US11773419B2Oct 3, 2023
Solid form of (-)-Ambrox formed by a bioconversion of homofarnesol in the presence of a biocatalyst
GIVAUDAN SA2 citations68
US12584153B2Mar 24, 2026
Enzyme-mediated process for making Amberketal and Amberketal homologues
GIVAUDAN SA0 citations62
US12391965B2Aug 19, 2025
Conversion of farnesylacetone to homofarnesylacetate by baeyer-villiger monooxygenase
GIVAUDAN SA0 citations61
US11965202B2Apr 23, 2024
Method of making 2-oxygenated decalins from isoprenoids using a squalene-hopene cyclase
GIVAUDAN SA0 citations61
US12416027B2Sep 16, 2025
Squalene hopene cyclase (SHC) variants
GIVAUDAN SA0 citations59
US12071645B2Aug 27, 2024
Enzymes and applications thereof
GIVAUDAN SA0 citations59
US12084699B2Sep 10, 2024
Solid form of (−)-Ambrox formed by a bioconversion of homofarnesol in the presence of a biocatalyst
GIVAUDAN SA0 citations57
US11401541B2Aug 2, 2022
Solid form of (-)-Ambrox formed by a bioconversion of homofarnesol in the presence of a biocatalyst
GIVAUDAN SA0 citations57
US12404531B2Sep 2, 2025
Method for purifying (−)-Ambrox
GIVAUDAN SA0 citations50
US10294211B2May 21, 2019
Process for isolating and purifying ambrox
GIVAUDAN SA0 citations50